Our data demonstrated that sponsor and study phase are important factors to be taken into consideration when estimating clinical trial costs and resource use.
Purpose: The Ontario Institute for Cancer Research supported the creation of a working group with the objective of developing a standard rating scale to evaluate clinical trial complexity and applying the scale to facilitate workload measurement for Ontario cancer research sites.
Methods:The lack of a mechanism to measure the workload involved in a clinical trials protocol was identified and confirmed by a literature review. To collect information on how Ontario sites were assessing workload, a survey was distributed and evaluated. As a result, the working group developed the Ontario Protocol Assessment Level (OPAL), a protocol complexity rating scale designed to capture the workload involved in a clinical trial. After a training workshop on the application, OPAL was evaluated by 17 Ontario cancer centers to demonstrate its reliability and consistency during a 3-month pilot study.Results: Twenty-seven protocols were reviewed by multiple sites, and the majority of the sites reported OPAL score differences between 0 and 1.5.
Conclusion: OPAL provides clinical trials departments with anobjective method of quantifying clinical trials activity on the basis of study protocol complexity. With consistent application of OPAL, sites can manage staffing objectively. The working group is continuing to monitor the application of OPAL in Ontario.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.